Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy
Hero
Our Approach
Simulations capture patient biology where experiments fail
Platform
Engineering a way to understand biology
Pipeline
A single platform to rationalize the entire R&D process
Meet Us
Building deep tech for deep biology
Notification
Join our mission
Read about us
Hero
Our Approach
Platform
Pipeline
Meet Us
Notification
Join our mission
Read about us
Roche named Turbine as one of the most disruptive health technologies
09 November 2017
back
01 April 2024
Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy
read more
29 February 2024
Turbine joins Ginkgo Bioworks’ Technology Network as Inaugural Partner
read more
All rights reserved ©2024 Turbine Ltd. |
Privacy Policy
|
Created by Art&Board Studio
close
Turbine presents poster at AACR Annual Meeting 2024: Simulation driven identification of combinations for the WEE1 inhibitor Debio 0123 results in synergistic effect with cabozantinib validated
in vivo
